Neonatology

Review

Free Access

Congenital Diaphragmatic Hernia: Comparison of Animal Models and Relevance to the Human Situation

van Loenhout R.B.a, b · Tibboel D.b · Post M.a · Keijzer R.a, b

Author affiliations

aProgram in Physiology and Experimental Medicine, Hospital for Sick Children, Toronto, Ont., Canada; bDepartment of Pediatric Surgery, Erasmus MC-Sophia, Rotterdam, The Netherlands

Corresponding Author

Richard Keijzer, MD, PhD, MSc

Erasmus MC-Sophia, Room SK-1254

Dr Molewaterplein 60

NL–3015 GJ Rotterdam (The Netherlands)

Tel. +31 10 704 6783, Fax +31 10 703 6802, E-Mail r.keijzer@erasmusmc.nl

Related Articles for ""

Neonatology 2009;96:137–149

Abstract

Congenital diaphragmatic hernia (CDH) occurs in 1 in 3,000 newborns. Mortality and morbidity are due to the amount of pulmonary hypoplasia (PH), the response on artificial ventilation and the presence of therapy-resistant pulmonary hypertension. The pathogenesis and etiology of CDH and its associated anomalies are still largely unknown despite all research efforts over the past years. Several animal models have been proposed to study CDH. In this review we compare surgical, pharmacological and transgenic models, and discuss their strengths and limitations to study PH.

© 2009 S. Karger AG, Basel




Related Articles:


References

  1. Langham MR Jr, Kays DW, Ledbetter DJ, Frentzen B, Sanford LL, Richards DS: Congenital diaphragmatic hernia. Epidemiology and outcome. Clin Perinatol 1996;23:671–688.
  2. Kays DW: Congenital diaphragmatic hernia and neonatal lung lesions. Surg Clin North Am 2006;86:329–352, IX.
  3. Rottier R, Tibboel D: Fetal lung and diaphragm development in congenital diaphragmatic hernia. Semin Perinatol 2005;29:86–93.
  4. Grosfeld JL, O’Neill JA, Fonkalsrud EW, Coran AG: Pediatric Surgery, ed 6. Philadelphia, Mosby-Elsevier, 2006, pp 931–954.
  5. Logan JW, Rice HE, Goldberg RN, Cotten CM: Congenital diaphragmatic hernia: a systematic review and summary of best-evidence practice strategies. J Perinatol 2007;27:535–549.
  6. Holder AM, Klaassens M, Tibboel D, de Klein A, Lee B, Scott DA: Genetic factors in congenital diaphragmatic hernia. Am J Hum Genet 2007;80:825–845.
  7. Delorimier AA, Tierney DF, Parker HR: Hypoplastic lungs in fetal lambs with surgically produced congenital diaphragmatic hernia. Surgery 1967;62:12–17.
    External Resources
  8. Lipsett J, Cool JC, Runciman SI, Ford WD, Kennedy JD, Martin AJ: Effect of antenatal tracheal occlusion on lung development in the sheep model of congenital diaphragmatic hernia: a morphometric analysis of pulmonary structure and maturity. Pediatr Pulmonol 1998;25:257–269.
  9. Flemmer AW, Jani JC, Bergmann F, Muensterer OJ, Gallot D, Hajek K, Sugawara J, Till H, Deprest JA: Lung tissue mechanics predict lung hypoplasia in a rabbit model for congenital diaphragmatic hernia. Pediatr Pulmonol 2007;42:505–512.
  10. Wu J, Yamamoto H, Gratacos E, Ge X, Verbeken E, Sueishi K, Hashimoto S, Vanamo K, Lerut T, Deprest J: Lung development following diaphragmatic hernia in the fetal rabbit. Hum Reprod 2000;15:2483–2488.
  11. Davey MG, Danzer E, Schwarz U, Adzick NS, Flake AW, Hedrick HL: Prenatal glucocorticoids and exogenous surfactant therapy improve respiratory function in lambs with severe diaphragmatic hernia following fetal tracheal occlusion. Pediatr Res 2006;60:131–135.
  12. Roubliova XI, Van der Biest AM, Vaast P, Lu H, Jani JC, Lewi PJ, Verbeken EK, Tibboel D, Deprest JA: Effect of maternal administration of betamethasone on peripheral arterial development in fetal rabbit lungs. Neonatology 2008;93:64–72.
  13. Ford WD, Cool J, Derham R: Intrathoracic silo for the potential antenatal repair of diaphragmatic herniae with liver in the chest. Fetal Diagn Ther 1992;7:75–81.
  14. Harrison MR, Adzick NS, Longaker MT, Goldberg JD, Rosen MA, Filly RA, Evans MI, Golbus MS: Successful repair in utero of a fetal diaphragmatic hernia after removal of herniated viscera from the left thorax. N Engl J Med 1990;322:1582–1584.
  15. Lipsett J, Cool JC, Runciman SC, Ford WD, Parsons DW, Kennedy JD, Martin AJ: Effect of immediate versus slow intrauterine reduction of congenital diaphragmatic hernia on lung development in the sheep: a morphometric analysis of term pulmonary structure and maturity. Pediatr Pulmonol 2000;30:228–240.
  16. De Paepe ME, Johnson BD, Papadakis K, Luks FI: Lung growth response after tracheal occlusion in fetal rabbits is gestational age-dependent. Am J Respir Cell Mol Biol 1999;21:65–76.
  17. DiFiore JW, Fauza DO, Slavin R, Peters CA, Fackler JC, Wilson JM: Experimental fetal tracheal ligation reverses the structural and physiological effects of pulmonary hypoplasia in congenital diaphragmatic hernia. J Pediatr Surg 1994;29:248–256; discussion 256–257.
  18. Wilson JM, DiFiore JW, Peters CA: Experimental fetal tracheal ligation prevents the pulmonary hypoplasia associated with fetal nephrectomy: possible application for congenital diaphragmatic hernia. J Pediatr Surg 1993;28:1433–1439; discussion 1439–1440.
  19. Wigglesworth JS, Desai R, Hislop AA: Fetal lung growth in congenital laryngeal atresia. Pediatr Pathol 1987;7:515–525.
  20. Harrison MR, Adzick NS, Flake AW, VanderWall KJ, Bealer JF, Howell LJ, Farrell JA, Filly RA, Rosen MA, Sola A, Goldberg JD: Correction of congenital diaphragmatic hernia in utero. VIII. Response of the hypoplastic lung to tracheal occlusion. J Pediatr Surg 1996;31:1339–1348.
  21. Harrison MR, Mychaliska GB, Albanese CT, Jennings RW, Farrell JA, Hawgood S, Sandberg P, Levine AH, Lobo E, Filly RA: Correction of congenital diaphragmatic hernia in utero. IX. Fetuses with poor prognosis (liver herniation and low lung-to-head ratio) can be saved by fetoscopic temporary tracheal occlusion. J Pediatr Surg 1998;33:1017–1022; discussion 1022–1023.
  22. Harrison MR, Sydorak RM, Farrell JA, Kitterman JA, Filly RA, Albanese CT: Fetoscopic temporary tracheal occlusion for congenital diaphragmatic hernia: prelude to a randomized, controlled trial. J Pediatr Surg 2003;38:1012–1020.
  23. Bratu I, Flageole H, Laberge JM, Kovacs L, Faucher D, Piedboeuf B: Lung function in lambs with diaphragmatic hernia after reversible fetal tracheal occlusion. J Pediatr Surg 2004;39:1524–1531.
  24. Deprest JA, Evrard VA, Van Ballaer PP, Verbeken E, Vandenberghe K, Lerut TE, Flageole H: Tracheoscopic endoluminal plugging using an inflatable device in the fetal lamb model. Eur J Obstet Gynecol Reprod Biol 1998;81:165–169.
  25. Skarsgard ED, Meuli M, VanderWall KJ, Bealer JF, Adzick NS, Harrison MR: Fetal endoscopic tracheal occlusion (‘fetendo-plug’) for congenital diaphragmatic hernia. J Pediatr Surg 1996;31:1335–1338.
  26. Wu J, Ge X, Verbeken EK, Gratacos E, Yesildaglar N, Deprest JA: Pulmonary effects of in utero tracheal occlusion are dependent on gestational age in a rabbit model of diaphragmatic hernia. J Pediatr Surg 2002;37:11–17.
  27. Harrison MR, Keller RL, Hawgood SB, Kitterman JA, Sandberg PL, Farmer DL, Lee H, Filly RA, Farrell JA, Albanese CT: A randomized trial of fetal endoscopic tracheal occlusion for severe fetal congenital diaphragmatic hernia. N Engl J Med 2003;349:1916–1924.
  28. Roubliova XI, Verbeken EK, Wu J, Vaast P, Jani J, Deprest JA: Effect of tracheal occlusion on peripheric pulmonary vessel muscularization in a fetal rabbit model for congenital diaphragmatic hernia. Am J Obstet Gynecol 2004;191:830–836.
  29. Deprest J, Gratacos E, Nicolaides KH: Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia: evolution of a technique and preliminary results. Ultrasound Obstet Gynecol 2004;24:121–126.
  30. Lipshutz GS, Albanese CT, Feldstein VA, Jennings RW, Housley HT, Beech R, Farrell JA, Harrison MR: Prospective analysis of lung-to-head ratio predicts survival for patients with prenatally diagnosed congenital diaphragmatic hernia. J Pediatr Surg 1997;32:1634–1636.
  31. Deprest J, Jani J, Cannie M, Debeer A, Vandevelde M, Done E, Gratacos E, Nicolaides K: Prenatal intervention for isolated congenital diaphragmatic hernia. Curr Opin Obstet Gynecol 2006;18:355–367.
  32. Deprest J, Jani J, Gratacos E, Vandecruys H, Naulaers G, Delgado J, Greenough A, Nicolaides K: Fetal intervention for congenital diaphragmatic hernia: the European experience. Semin Perinatol 2005;29:94–103.
  33. Gucciardo L, Deprest J, Done E, Van Mieghem T, Van de Velde M, Gratacos E, Jani J, Peralta F, Nicolaides K: Prediction of outcome in isolated congenital diaphragmatic hernia and its consequences for fetal therapy. Best Pract Res Clin Obstet Gynaecol 2008;22:123–138.
  34. Jani J, Gratacos E, Greenough A, Piero JL, Benachi A, Harrison M, Nicolaides K, Deprest J: Percutaneous fetal endoscopic tracheal occlusion (FETO) for severe left-sided congenital diaphragmatic hernia. Clin Obstet Gynecol 2005;48:910–922.
  35. Jani JC, Nicolaides KH, Gratacos E, Vandecruys H, Deprest JA: Fetal lung-to-head ratio in the prediction of survival in severe left-sided diaphragmatic hernia treated by fetal endoscopic tracheal occlusion (FETO). Am J Obstet Gynecol 2006;195:1646–1650.
  36. Peralta CF, Jani JC, Van Schoubroeck D, Nicolaides KH, Deprest JA: Fetal lung volume after endoscopic tracheal occlusion in the prediction of postnatal outcome. Am J Obstet Gynecol 2008;198:60e61–60e65.
    External Resources
  37. Done E, Gucciardo L, Van Mieghem T, Jani J, Cannie M, Van Schoubroeck D, Devlieger R, Catte LD, Klaritsch P, Mayer S, Beck V, Debeer A, Gratacos E, Nicolaides K, Deprest J: Prenatal diagnosis, prediction of outcome and in utero therapy of isolated congenital diaphragmatic hernia. Prenat Diagn 2008;28:581–591.
  38. Bratu I, Flageole H, Laberge JM, Chen MF, Piedboeuf B: Pulmonary structural maturation and pulmonary artery remodeling after reversible fetal ovine tracheal occlusion in diaphragmatic hernia. J Pediatr Surg 2001;36:739–744.
  39. Luks FI, Wild YK, Piasecki GJ, De Paepe ME: Short-term tracheal occlusion corrects pulmonary vascular anomalies in the fetal lamb with diaphragmatic hernia. Surgery 2000;128:266–272.
  40. Sylvester KG, Rasanen J, Kitano Y, Flake AW, Crombleholme TM, Adzick NS: Tracheal occlusion reverses the high impedance to flow in the fetal pulmonary circulation and normalizes its physiological response to oxygen at full term. J Pediatr Surg 1998;33:1071–1074; discussion 1074–1075.
  41. de Buys Roessingh AS, de Lagausie P, Barbet JP, Mercier JC, Aigrain Y, Dinh-Xuan AT: Role of ATP-dependent potassium channels in pulmonary vascular tone of fetal lambs with congenital diaphragmatic hernia. Pediatr Res 2006;60:537–542.
  42. de Buys Roessingh AS, de Lagausie P, Ibrahima T, Duong-Quy S, Schneider JC, Huang XL, Mercier JC, Aigrain Y, Boulanger C, Dinh-Xuan AT: Neuronal nitric oxide synthase does not contribute to the modulation of pulmonary vascular tone in fetal lambs with congenital diaphragmatic hernia (NNOS in CDH lambs). Pediatr Pulmonol 2008;43:313–321.
  43. Roubliova X, Verbeken E, Wu J, Yamamoto H, Lerut T, Tibboel D, Deprest J: Pulmonary vascular morphology in a fetal rabbit model for congenital diaphragmatic hernia. J Pediatr Surg 2004;39:1066–1072.
  44. Harrison MR, Jester JA, Ross NA: Correction of congenital diaphragmatic hernia in utero. I. The model: intrathoracic balloon produces fatal pulmonary hypoplasia. Surgery 1980;88:174–182.
  45. Ohi R, Suzuki H, Kato T, Kasai M: Development of the lung in fetal rabbits with experimental diaphragmatic hernia. J Pediatr Surg 1976;11:955–959.
  46. Bratu I, Flageole H, Laberge JM, Possmayer F, Harbottle R, Kay S, Khalife S, Piedboeuf B: Surfactant levels after reversible tracheal occlusion and prenatal steroids in experimental diaphragmatic hernia. J Pediatr Surg 2001;36:122–127.
  47. Tannuri U, Rodrigues CJ, Maksoud-Filho JG, Santos MM, Tannuri AC, Rodrigues AJ Jr: The effects of prenatal intra-amniotic surfactant or dexamethasone administration on lung development are comparable to changes induced by tracheal ligation in an animal model of congenital diaphragmatic hernia: studies of lung glycogen content, elastic fiber density, and collagen content. J Pediatr Surg 1998;33:1776–1783.
  48. Keijzer R, Liu J, Deimling J, Tibboel D, Post M: Dual-hit hypothesis explains pulmonary hypoplasia in the nitrofen model of congenital diaphragmatic hernia. Am J Pathol 2000;156:1299–1306.
  49. Costlow RD, Manson JM: The heart and diaphragm: target organs in the neonatal death induced by nitrofen (2,4-dichlorophenyl-p-nitrophenyl ether). Toxicology 1981;20:209–227.
  50. Ambrose AM, Larson PS, Borzelleca JF, Smith RB Jr, Hennigar GR Jr: Toxicologic studies on 2,4-dichlorophenyl-p-nitrophenyl ether. Toxicol Appl Pharmacol 1971;19:263–275.
  51. Migliazza L, Otten C, Xia H, Rodriguez JI, Diez-Pardo JA, Tovar JA: Cardiovascular malformations in congenital diaphragmatic hernia: human and experimental studies. J Pediatr Surg 1999;34:1352–1358.
  52. Migliazza L, Xia H, Alvarez JI, Arnaiz A, Diez-Pardo JA, Alfonso LF, Tovar JA: Heart hypoplasia in experimental congenital diaphragmatic hernia. J Pediatr Surg 1999;34:706–710; discussion 710–711.
  53. Migliazza L, Xia H, Diez-Pardo JA, Tovar JA: Skeletal malformations associated with congenital diaphragmatic hernia: experimental and human studies. J Pediatr Surg 1999;34:1624–1629.
  54. Tenbrinck R, Tibboel D, Gaillard JL, Kluth D, Bos AP, Lachmann B, Molenaar JC: Experimentally induced congenital diaphragmatic hernia in rats. J Pediatr Surg 1990;25:426–429.
  55. Andersen DH: Incidence of congenital diaphragmatic hernia in the young of rats bred on a diet deficient in vitamin A. Am J Dis Child 1941;62:888–889.
  56. Wilson JG, Roth CB, Warkany J: An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation. Am J Anat 1953;92:189–217.
  57. Mendelsohn C, Lohnes D, Decimo D, Lufkin T, LeMeur M, Chambon P, Mark M: Function of the RA receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 1994;120:2749–2771.
  58. Major D, Cadenas M, Fournier L, Leclerc S, Lefebvre M, Cloutier R: Retinol status of newborn infants with congenital diaphragmatic hernia. Pediatr Surg Int 1998;13:547–549.
  59. Enns GM, Cox VA, Goldstein RB, Gibbs DL, Harrison MR, Golabi M: Congenital diaphragmatic defects and associated syndromes, malformations, and chromosome anomalies: a retrospective study of 60 patients and literature review. Am J Med Genet 1998;79:215–225.
  60. Biggio JR Jr, Descartes MD, Carroll AJ, Holt RL: Congenital diaphragmatic hernia: is 15q26.1–26.2 a candidate locus? Am J Med Genet A 2004;126:183–185.
    External Resources
  61. Greer JJ, Babiuk RP, Thebaud B: Etiology of congenital diaphragmatic hernia: the retinoid hypothesis. Pediatr Res 2003;53:726–730.
  62. Iritani I: Experimental study on embryogenesis of congenital diaphragmatic hernia. Anat Embryol (Berl) 1984;169:133–139.
  63. Kluth D, Tenbrinck R, von Ekesparre M, Kangah R, Reich P, Brandsma A, Tibboel D, Lambrecht W: The natural history of congenital diaphragmatic hernia and pulmonary hypoplasia in the embryo. J Pediatr Surg 1993;28:456–462; discussion 462–463.
  64. Montedonico S, Nakazawa N, Puri P: Retinoic acid rescues lung hypoplasia in nitrofen-induced hypoplastic foetal rat lung explants. Pediatr Surg Int 2006;22:2–8.
  65. Thebaud B, Barlier-Mur AM, Chailley-Heu B, Henrion-Caude A, Tibboel D, Dinh-Xuan AT, Bourbon JR: Restoring effects of vitamin A on surfactant synthesis in nitrofen-induced congenital diaphragmatic hernia in rats. Am J Respir Crit Care Med 2001;164:1083–1089.
  66. Thebaud B, Tibboel D, Rambaud C, Mercier JC, Bourbon JR, Dinh-Xuan AT, Archer SL: Vitamin A decreases the incidence and severity of nitrofen-induced congenital diaphragmatic hernia in rats. Am J Physiol 1999;277:L423–L429.
  67. Babiuk RP, Thebaud B, Greer JJ: Reductions in the incidence of nitrofen-induced diaphragmatic hernia by vitamin A and retinoic acid. Am J Physiol Lung Cell Mol Physiol 2004;286:L970–L973.
  68. Duester G: Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem 2000;267:4315–4324.
  69. Duester G: Involvement of alcohol dehydrogenase, short-chain dehydrogenase/reductase, aldehyde dehydrogenase, and cytochrome p450 in the control of retinoid signaling by activation of retinoic acid synthesis. Biochemistry 1996;35:12221–12227.
  70. Hind M, Corcoran J, Maden M: Alveolar proliferation, retinoid synthesizing enzymes, and endogenous retinoids in the postnatal mouse lung. Different roles for ALDH-1 and RALDH-2. Am J Respir Cell Mol Biol 2002;26:67–73.
  71. Mey J, Babiuk RP, Clugston R, Zhang W, Greer JJ: Retinal dehydrogenase-2 is inhibited by compounds that induce congenital diaphragmatic hernias in rodents. Am J Pathol 2003;162:673–679.
  72. Noble BR, Babiuk RP, Clugston RD, Underhill TM, Sun H, Kawaguchi R, Walfish PG, Blomhoff R, Gundersen TE, Greer JJ: Mechanisms of action of the congenital diaphragmatic hernia-inducing teratogen nitrofen. Am J Physiol Lung Cell Mol Physiol 2007;293:L1079–L1087.
  73. Nakazawa N, Montedonico S, Takayasu H, Paradisi F, Puri P: Disturbance of retinol transportation causes nitrofen-induced hypoplastic lung. J Pediatr Surg 2007;42:345–349.
  74. Golzio C, Martinovic-Bouriel J, Thomas S, Mougou-Zrelli S, Grattagliano-Bessières B, Bonnière M, Delahaye S, Munnich A, Encha-Razavi F, Lyonnet S, Vekemans M, Attie-Bitach T, Etchevers HC: Matthew-Wood syndrome is caused by truncating mutations in the retinol-binding protein receptor gene STRA6. Am J Hum Genet 2007;80:1179–1187.
  75. Kawaguchi R, Yu J, Honda J, Hu J, Whitelegge J, Ping P, Wiita P, Bok D, Sun H: A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 2007;315:820–825.
  76. Pasutto F, Sticht H, Hammersen G, Gillessen-Kaesbach G, Fitzpatrick DR, Nurnberg G, Brasch F, Schirmer-Zimmermann H, Tolmie JL, Chitayat D, Houge G, Fernandez-Martinez L, Keating S, Mortier G, Hennekam RC, von der Wense A, Slavotinek A, Meinecke P, Bitoun P, Becker C, Nurnberg P, Reis A, Rauch A: Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. Am J Hum Genet 2007;80:550–560.
  77. Ross AC: Retinoid production and catabolism: role of diet in regulating retinol esterification and retinoic acid oxidation. J Nutr 2003;133:291S–296S.
  78. Reijntjes S, Blentic A, Gale E, Maden M: The control of morphogen signalling: regulation of the synthesis and catabolism of retinoic acid in the developing embryo. Dev Biol 2005;285:224–237.
  79. Chinoy MR, Chi X, Cilley RE: Down-regulation of regulatory proteins for differentiation and proliferation in murine fetal hypoplastic lungs: Altered mesenchymal-epithelial interactions. Pediatr Pulmonol 2001;32:129–141.
  80. Chen MH, MacGowan A, Ward S, Bavik C, Greer JJ: The activation of the retinoic acid response element is inhibited in an animal model of congenital diaphragmatic hernia. Biol Neonate 2003;83:157–161.
  81. Rajatapiti P, Keijzer R, Blommaart PE, Lamers WH, De Krijger RR, Visser TJ, Tibboel D, Rottier R: Spatial and temporal expression of glucocorticoid, retinoid, and thyroid hormone receptors is not altered in lungs of congenital diaphragmatic hernia. Pediatr Res 2006;60:693–698.
  82. Utiger RD: Thyroid hormone synthesis and physiology (2008). Retrieved June 27, 2008, at: http://www.utdol.com.
  83. Gray LE Jr, Kavlock RJ: The effects of the herbicide 2,4-dichlorophenyl-p-nitrophenyl ether (NIT) on serum thyroid hormones in adult female mice. Toxicol Lett 1983;15:231–235.
  84. Manson JM, Brown T, Baldwin DM: Teratogenicity of nitrofen (2,4-dichloro-4′-nitrodiphenyl ether) and its effects on thyroid function in the rat. Toxicol Appl Pharmacol 1984;73:323–335.
  85. Brandsma AE, Tibboel D, Vulto IM, de Vijlder JJ, Ten Have-Opbroek AA, Wiersinga WM: Inhibition of T3-receptor binding by nitrofen. Biochim Biophys Acta 1994;1201:266–270.
  86. Ayromlooi J, Berg PD, Valderrama E, Tobias MD: Midtrimester thyroidectomy in the ovine fetus. Pediatr Pharmacol (New York) 1983;3:15–28.
  87. Holt J, Canavan JP, Goldspink DF: The influence of thyroid hormones on the growth of the lungs in perinatal rats. Int J Dev Biol 1993;37:467–472.
  88. Keijzer R, Blommaart PJ, Labruyere WT, Vermeulen JL, Doulabi BZ, Bakker O, Tibboel D, Lamers WH: Expression of thyroid hormone receptors A and B in developing rat tissues; evidence for extensive posttranscriptional regulation. J Mol Endocrinol 2007;38:523–535.
  89. Perez-Castillo A, Bernal J, Ferreiro B, Pans T: The early ontogenesis of thyroid hormone receptor in the rat fetus. Endocrinology 1985;117:2457–2461.
  90. Bradley DJ, Towle HC, Young WS 3rd: Spatial and temporal expression of α- and β-thyroid hormone receptor MRNAs, including the β2-subtype, in the developing mammalian nervous system. J Neurosci 1992;12:2288–2302.
  91. Morreale de Escobar G, Pastor R, Obregon MJ, Escobar del Rey F: Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues, before and after onset of fetal thyroid function. Endocrinology 1985;117:1890–1900.
  92. Obregon MJ, Mallol J, Pastor R, Morreale de Escobar G, Escobar del Rey F: L-thyroxine and 3,5,3′-triiodo-L-thyronine in rat embryos before onset of fetal thyroid function. Endocrinology 1984;114:305–307.
  93. Vulsma T, Gons MH, de Vijlder JJ: Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 1989;321:13–16.
  94. Manson JM: Mechanism of nitrofen teratogenesis. Environ Health Perspect 1986;70:137–147.
  95. Tovar JA, Qi B, Diez-Pardo JA, Alfonso LF, Arnaiz A, Alvarez FJ, Valls-i-Soler A, Morreale de Escobar G: Thyroid hormones in the pathogenesis of lung hypoplasia and immaturity induced in fetal rats by prenatal exposure to nitrofen. J Pediatr Surg 1997;32:1295–1297.
  96. Teramoto H, Guarino N, Puri P: Altered gene level expression of thyroid hormone receptors alpha-1 and beta-1 in the lung of nitrofen-induced diaphragmatic hernia. J Pediatr Surg 2001;36:1675–1678.
  97. Fraichard A, Chassande O, Plateroti M, Roux JP, Trouillas J, Dehay C, Legrand C, Gauthier K, Kedinger M, Malaval L, Rousset B, Samarut J: The T3R alpha gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production. Embo J 1997;16:4412–4420.
  98. van Tuyl M, Blommaart PE, de Boer PA, Wert SE, Ruijter JM, Islam S, Schnitzer J, Ellison AR, Tibboel D, Moorman AF, Lamers WH: Prenatal exposure to thyroid hormone is necessary for normal postnatal development of murine heart and lungs. Dev Biol 2004;272:104–117.
  99. Belik J, Davidge ST, Zhang W, Pan J, Greer JJ: Airway smooth muscle changes in the nitrofen-induced congenital diaphragmatic hernia rat model. Pediatr Res 2003;53:737–743.
  100. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT-1 is required for early kidney development. Cell 1993;74:679–691.
  101. Clugston RD, Klattig J, Englert C, Clagett-Dame M, Martinovic J, Benachi A, Greer JJ: Teratogen-induced, dietary and genetic models of congenital diaphragmatic hernia share a common mechanism of pathogenesis. Am J Pathol 2006;169:1541–1549.
  102. Cho HY, Lee BS, Kang CH, Kim WH, Ha IS, Cheong HI, Choi Y: Hydrothorax in a patient with Denys-Drash syndrome associated with a diaphragmatic defect. Pediatr Nephrol 2006;21:1909–1912.
  103. Nordenskjold A, Friedman E, Anvret M: WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin. Hum Genet 1994;93:115–120.
  104. Scott DA, Cooper ML, Stankiewicz P, Patel A, Potocki L, Cheung SW: Congenital diaphragmatic hernia in WAGR syndrome. Am J Med Genet A 2005;134:430–433.
  105. Antonius T, van Bon B, Eggink A, van der Burgt I, Noordam K, van Heijst A: Denys-Drash syndrome and congenital diaphragmatic hernia: another case with the 1097G > A(arg366His) mutation. Am J Med Genet A 2008;146:496–499.
  106. Nordenskjold A, Tapper-Persson M, Anvret M: No evidence of WT1 gene mutations in children with congenital diaphragmatic hernia. J Pediatr Surg 1996;31:925–927.
  107. Villavicencio EH, Walterhouse DO, Iannaccone PM: The sonic hedgehog-patched-gli pathway in human development and disease. Am J Hum Genet 2000;67:1047–1054.
  108. Litingtung Y, Lei L, Westphal H, Chiang C: Sonic hedgehog is essential to foregut development. Nat Genet 1998;20:58–61.
  109. Motoyama J, Liu J, Mo R, Ding Q, Post M, Hui CC: Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus. Nat Genet 1998;20:54–57.
  110. Pepicelli CV, Lewis PM, McMahon AP: Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr Biol 1998;8:1083–1086.
  111. Unger S, Copland I, Tibboel D, Post M: Down-regulation of sonic hedgehog expression in pulmonary hypoplasia is associated with congenital diaphragmatic hernia. Am J Pathol 2003;162:547–555.
  112. Kim PC, Mo R, Hui Cc C: Murine models of VACTERL syndrome: role of sonic hedgehog signaling pathway. J Pediatr Surg 2001;36:381–384.
  113. Brose K, Tessier-Lavigne M: Slit proteins: key regulators of axon guidance, axonal branching, and cell migration. Curr Opin Neurobiol 2000;10:95–102.
  114. Liu J, Zhang L, Wang D, Shen H, Jiang M, Mei P, Hayden PS, Sedor JR, Hu H: Congenital diaphragmatic hernia, kidney agenesis and cardiac defects associated with Slit3-deficiency in mice. Mech Dev 2003;120:1059–1070.
  115. Yuan W, Rao Y, Babiuk RP, Greer JJ, Wu JY, Ornitz DM: A genetic model for a central (septum transversum) congenital diaphragmatic hernia in mice lacking Slit3. Proc Natl Acad Sci USA 2003;100:5217–5222.
  116. Sharma S, Jain R, Singh MK, Gupta DK: A case of congenital diaphragmatic hernia with a hernia sac attached to the liver: hints for an early embryological insult. J Pediatr Surg 2007;42:1761–1763.
  117. Ackerman KG, Herron BJ, Vargas SO, Huang H, Tevosian SG, Kochilas L, Rao C, Pober BR, Babiuk RP, Epstein JA, Greer JJ, Beier DR: Fog2 is required for normal diaphragm and lung development in mice and humans. PLoS Genet 2005;1:58–65.
  118. Guilbert TW, Gebb SA, Shannon JM: Lung hypoplasia in the nitrofen model of congenital diaphragmatic hernia occurs early in development. Am J Physiol Lung Cell Mol Physiol 2000;279:L1159–L1171.
  119. Jesudason EC, Connell MG, Fernig DG, Lloyd DA, Losty PD: Early lung malformations in congenital diaphragmatic hernia. J Pediatr Surg 2000;35:124–127; discussion 128.
  120. Bleyl SB, Moshrefi A, Shaw GM, Saijoh Y, Schoenwolf GC, Pennacchio LA, Slavotinek AM: Candidate genes for congenital diaphragmatic hernia from animal models: sequencing of FOG2 and PDGFRα reveals rare variants in diaphragmatic hernia patients. Eur J Hum Genet 2007;15:950–958.
  121. Kuo CT, Morrisey EE, Anandappa R, Sigrist K, Lu MM, Parmacek MS, Soudais C, Leiden JM: GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev 1997;11:1048–1060.
  122. Molkentin JD, Lin Q, Duncan SA, Olson EN: Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev 1997;11:1061–1072.
  123. Morrisey EE, Tang Z, Sigrist K, Lu MM, Jiang F, Ip HS, Parmacek MS: GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo. Genes Dev 1998;12:3579–3590.
  124. Kimura S: homeodomain transcription factor T/EBP/NKX2.1 in development and differentiation of the thyroid and lung (in Japanese). Seikagaku 2003;75:1493–1504.
  125. Molkentin JD: The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 2000;275:38949–38952.
  126. Whitsett JA, Tichelaar JW: Forkhead transcription factor HFH-4 and respiratory epithelial cell differentiation. Am J Respir Cell Mol Biol 1999;21:153–154.
  127. Jay PY, Bielinska M, Erlich JM, Mannisto S, Pu WT, Heikinheimo M, Wilson DB: Impaired mesenchymal cell function in GATA4 mutant mice leads to diaphragmatic hernias and primary lung defects. Dev Biol 2007;301:602–614.
  128. Ackerman KG, Wang J, Luo L, Fujiwara Y, Orkin SH, Beier DR: GATA4 is necessary for normal pulmonary lobar development. Am J Respir Cell Mol Biol 2007;36:391–397.
  129. Barber JC, Maloney V, Hollox EJ, Stuke-Sontheimer A, du Bois G, Daumiller E, Klein-Vogler U, Dufke A, Armour JA, Liehr T: Duplications and copy number variants of 8p23.1 are cytogenetically indistinguishable but distinct at the molecular level. Eur J Hum Genet 2005;13:1131–1136.
  130. Devriendt K, Matthijs G, Van Dael R, Gewillig M, Eyskens B, Hjalgrim H, Dolmer B, McGaughran J, Brondum-Nielsen K, Marynen P, Fryns JP, Vermeesch JR: Delineation of the critical deletion region for congenital heart defects, on chromosome 8p23.1. Am J Hum Genet 1999;64:1119–1126.
  131. Faivre L, Morichon-Delvallez N, Viot G, Narcy F, Loison S, Mandelbrot L, Aubry MC, Raclin V, Edery P, Munnich A, Vekemans M: Prenatal diagnosis of an 8p23.1 deletion in a fetus with a diaphragmatic hernia and review of the literature. Prenat Diagn 1998;18:1055–1060.
  132. Shimokawa O, Miyake N, Yoshimura T, Sosonkina N, Harada N, Mizuguchi T, Kondoh S, Kishino T, Ohta T, Remco V, Takashima T, Kinoshita A, Yoshiura K, Niikawa N, Matsumoto N: Molecular characterization of del(8)(p23.1p23.1) in a case of congenital diaphragmatic hernia. Am J Med Genet A 2005;136:49–51.
    External Resources
  133. Pereira FA, Qiu Y, Zhou G, Tsai MJ, Tsai SY: The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev 1999;13:1037–1049.
  134. You LR, Takamoto N, Yu CT, Tanaka T, Kodama T, Demayo FJ, Tsai SY, Tsai MJ: Mouse lacking COUP-TFII as an animal model of Bochdalek-type congenital diaphragmatic hernia. Proc Natl Acad Sci USA 2005;102:16351–16356.
  135. Klaassens M, van Dooren M, Eussen HJ, Douben H, den Dekker AT, Lee C, Donahoe PK, Galjaard RJ, Goemaere N, de Krijger RR, Wouters C, Wauters J, Oostra BA, Tibboel D, de Klein A: Congenital diaphragmatic hernia and chromosome 15q26: determination of a candidate region by use of fluorescent in situ hybridization and array-based comparative genomic hybridization. Am J Hum Genet 2005;76:877–882.
  136. Scott DA, Klaassens M, Holder AM, Lally KP, Fernandes CJ, Galjaard RJ, Tibboel D, de Klein A, Lee B: Genome-wide oligonucleotide-based array comparative genome hybridization analysis of non-isolated congenital diaphragmatic hernia. Hum Mol Genet 2007;16:424–430.
  137. Clarke ID, Dirks PB: A human brain tumor-derived PDGFR-α deletion mutant is transforming. Oncogene 2003;22:722–733.
  138. Corless CL, Schroeder A, Griffith D, Town A, McGreevey L, Harrell P, Shiraga S, Bainbridge T, Morich J, Heinrich MC: PDGFRα mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol 2005;23:5357–5364.
  139. Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, Kitamura Y: Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors. Gastroenterology 2003;125:660–667.
  140. Rand V, Huang J, Stockwell T, Ferriera S, Buzko O, Levy S, Busam D, Li K, Edwards JB, Eberhart C, Murphy KM, Tsiamouri A, Beeson K, Simpson AJ, Venter JC, Riggins GJ, Strausberg RL: Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas. Proc Natl Acad Sci USA 2005;102:14344–14349.
  141. Slavotinek AM: Fryns syndrome: a review of the phenotype and diagnostic guidelines. Am J Med Genet A 2004;124:427–433.
    External Resources
  142. Pereira FA, Tsai MJ, Tsai SY: COUP-TF orphan nuclear receptors in development and differentiation. Cell Mol Life Sci 2000;57:1388–1398.
  143. Kostetskii I, Jiang Y, Kostetskaia E, Yuan S, Evans T, Zile M: Retinoid signaling required for normal heart development regulates GATA-4 in a pathway distinct from cardiomyocyte differentiation. Dev Biol 1999;206:206–218.
  144. Li E, Sucov HM, Lee KF, Evans RM, Jaenisch R: Normal development and growth of mice carrying a targeted disruption of the alpha1 retinoic acid receptor gene. Proc Natl Acad Sci USA 1993;90:1590–1594.
  145. Lohnes D, Kastner P, Dierich A, Mark M, LeMeur M, Chambon P: Function of retinoic acid receptor gamma in the mouse. Cell 1993;73:643–658.
  146. Lufkin T, Lohnes D, Mark M, Dierich A, Gorry P, Gaub MP, LeMeur M, Chambon P: High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc Natl Acad Sci USA 1993;90:7225–7229.
  147. Mendelsohn C, Mark M, Dolle P, Dierich A, Gaub MP, Krust A, Lampron C, Chambon P: Retinoic acid receptor beta 2 (RAR beta 2) null mutant mice appear normal. Dev Biol 1994;166:246–258.
  148. Mayer S, Klaritsch P, Sbragia L, Toelen J, Till H, Deprest JA: Maternal administration of betamethasone inhibits proliferation induced by fetal tracheal occlusion in the nitrofen rat model for congenital diaphragmatic hernia: a placebo-controlled study. Pediatr Surg Int 2008;24:1287–1295.
  149. Kantarci S, Casavant D, Prada C, Russell M, Byrne J, Haug LW, Jennings R, Manning S, Blaise F, Boyd TK, Fryns JP, Holmes LB, Donahoe PK, Lee C, Kimonis V, Pober BR: Findings from ACGH in patients with congenital diaphragmatic hernia (CDH): a possible locus for Fryns syndrome. Am J Med Genet A 2006;140:17–23.
  150. Slavotinek A, Lee SS, Davis R, Shrit A, Leppig KA, Rhim J, Jasnosz K, Albertson D, Pinkel D: Fryns syndrome phenotype caused by chromosome microdeletions at 15q26.2 and 8p23.1. J Med Genet 2005;42:730–736.

Article / Publication Details

First-Page Preview
Abstract of Review

Published online: March 27, 2009
Issue release date: September 2009

Number of Print Pages: 13
Number of Figures: 2
Number of Tables: 0

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP